At the beginning of April, the five-member delegation of Medical University - Varna returned from a working visit to Israel. Within the three-day visit, Prof. Krasimir Metodiev, Prof. Krasimir Gigov, Assoc. Prof. Plamen Panayotov, Assoc. Prof. Kaloyan Georgiev and Dr. Daniela Panayotova discussed the cooperation in the field of clinical practice, research, and anti-terrorist actions with the two University Hospitals - Hadassah in Jerusalem and Rambam in Haifa.
Throughout the visit to Hadassah University Hospital, working groups were set up and there were discussions on the implementation of already established joint projects between the University Hospital in Varna and the Hospital in Jerusalem. The projects are related to the long-term qualification programmes for Bulgarian medical practitioners in Hadassah, in the field of Cardiology, Cardiac Surgery, Dermatology and Intensive Medicine, and the exchange of guest lecturers. Furthermore, there were discussions on projects whose implementation had already started at St. Marina University Hospital, which are related to Bone Marrow Transplantation, Immunotherapy, Radiotherapy, etc. The forthcoming Third International Workshop on Anti-terrorism in Varna, which is to be held in June, provoked a discussion with the heads of the anti-terrorism unit at the medical institution. At the meeting, it transpired that leading experts in mass riots, natural disasters and terrorism from Hadassah Hospital will be among the lecturers at the forum.
At the prescheduled meetings at Rambam University Hospital, the representatives of MU-Varna discussed the anti-terrorism joint projects with their Israeli colleagues. There was also a discussion on the training opportunities for our postgraduates in a variety of practical, research and clinical laboratory projects. The visit ended with a visit to the Clinics in Cardiology and Cardiac Surgery, the newly opened Pediatric Oncology Department and the unique underground mobilisation hospital, with more than 2200 beds.
The programme of the delegation also included a meeting with the Directors for International Cooperation and Projects of Teva Pharmaceutical Company, where a number of issues concerning the future cooperation, including theoretical and practical aspects of pharmaceutical policy, were discussed.
